Skip to main content
. 2018 Dec 4;35(4):581–590. doi: 10.1007/s12264-018-0315-6

Table 1.

Demographics and clinical characteristics of all participants.

Psychotic PBD
Mean (SD)
Non-psychotic PBD
Mean (SD)
Healthy controls
Mean (SD)
t/F/χ 2 P value
Age 15.28 (1.57) 14.7 (2.10) 14.11 (1.61) 2.277 0.111
Gender (male/female) 11/14 12/11 7/11 0.753 0.686
Education (years) 8.16 (1.43) 7.96 (2.23) 7.39 (2.25) 0.829 0.441
IQ 100.56 (14.9) 103.78 (12.77) 106.28 (6.40) 1.155 0.322
Illness duration (months) 16.20 (11.89) 14.96 (13.01) 0.346 0.731
Onset age (years) 13.96 (1.46) 13.39 (1.92) 1.16 0.252
Episode times (years) 3.40 (1.53) 3.17 (2.42) 0.390 0.698
BD-I/BD-II 14/11 15/8 0.426 0.514
YMRS 16.16 (14.47)a 15.96 (14.79)a 3.67 (2.11) 6.394 0.003
MFQ 16.56 (14.36)a 13.30 (11.60)b 6.11 (3.43) 4.510 0.015
PSQI 5.48 (3.66) 7.26 (4.07)a 4.00 (2.45) 4.364 0.017
BSIS 3.20 (4.95) 2.87 (3.46) 1.22 (2.16) 1.513 0.228
PBD-manic 7 (28.0%) 7 (34.6%)
PBD-depression 8 (32.0%) 7 (30.8%)
PBD-remitted 10 (40.0%) 9 (34.6%) 0.036 0.982
Family history (yes/no) 4/21 7/16 1.413 0.235
Medication, n (%) 4 (16.0%) 9 (39.1%) 3.245 0.072

PBD, pediatric bipolar disorder; IQ, intelligence quotient; YMRS, Young Mania Rating Scale; MFQ, Mood and Feelings Questionnaire; PSQI, Pittsburgh Sleep Quality Index; BSIS, Beck Suicide Ideation Scale.

aP < 0.01 compared to healthy controls.

bP < 0.05 compared to healthy controls.